Persister state-directed transitioning and vulnerability in melanoma.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
01 06 2022
Historique:
received: 19 02 2021
accepted: 10 05 2022
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 7 6 2022
Statut: epublish

Résumé

Melanoma is a highly plastic tumor characterized by dynamic interconversion of different cell identities depending on the biological context. Melanoma cells with high expression of the H3K4 demethylase KDM5B (JARID1B) rest in a slow-cycling, yet reversible persister state. Over time, KDM5B

Identifiants

pubmed: 35650266
doi: 10.1038/s41467-022-30641-9
pii: 10.1038/s41467-022-30641-9
pmc: PMC9160289
doi:

Substances chimiques

Monophenol Monooxygenase EC 1.14.18.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3055

Subventions

Organisme : NCI NIH HHS
ID : R01 CA238237
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA010815
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA174523
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA224070
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA114046
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA261608
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Nature. 2017 Nov 9;551(7679):247-250
pubmed: 29088702
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Exp Dermatol. 2015 Sep;24(9):657-8
pubmed: 26010519
Cell Cycle. 2014;13(17):2744-51
pubmed: 25486361
Cell Rep. 2013 Sep 26;4(6):1090-9
pubmed: 24055054
Mol Cell Biol. 2008 Sep;28(17):5312-27
pubmed: 18591252
Nat Genet. 2021 Jan;53(1):76-85
pubmed: 33398196
Front Oncol. 2018 May 24;8:173
pubmed: 29881716
Cell Rep. 2020 Nov 24;33(8):108421
pubmed: 33238129
Biochem Biophys Rep. 2021 Feb 01;25:100916
pubmed: 33553685
Cold Spring Harb Protoc. 2015 Aug 03;2015(8):769-72
pubmed: 26240403
Cancer Cell. 2013 Jun 10;23(6):811-25
pubmed: 23764003
Nucleic Acids Res. 2016 Dec 15;44(22):11033
pubmed: 27683222
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
Cell. 2008 Feb 8;132(3):487-98
pubmed: 18267078
Cell. 2010 Apr 2;141(1):69-80
pubmed: 20371346
Pigment Cell Melanoma Res. 2014 Sep;27(5):764-76
pubmed: 24902993
Cell. 2007 Mar 23;128(6):1063-76
pubmed: 17320161
Cancer Res. 2008 Feb 15;68(4):989-97
pubmed: 18281472
Cancer Cell. 2013 Jul 8;24(1):105-19
pubmed: 23792190
Nat Cell Biol. 2014 Jun;16(6):561-73
pubmed: 24859005
J Med Chem. 2008 Apr 10;51(7):2018-26
pubmed: 18324763
J Invest Dermatol. 2019 Dec;139(12):2506-2516.e10
pubmed: 31229500
Nat Med. 2019 Dec;25(12):1916-1927
pubmed: 31792460
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Cell Cycle. 2006 Aug;5(16):1744-50
pubmed: 16861927
Methods Mol Biol. 2017;1612:401-416
pubmed: 28634959
Dev Cell. 2014 Dec 8;31(5):525-38
pubmed: 25490264
EMBO Rep. 2018 Dec;19(12):
pubmed: 30413482
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
EMBO J. 2011 Nov 16;30(22):4586-600
pubmed: 22020125
Cell. 2018 May 31;173(6):1413-1425.e14
pubmed: 29754815
J Cell Sci. 2011 Oct 1;124(Pt 19):3199-207
pubmed: 21940792
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Expert Opin Drug Discov. 2008 Jan;3(1):1-10
pubmed: 23480136
J Biol Chem. 1985 Mar 25;260(6):3440-50
pubmed: 3838314
Am J Pathol. 2005 May;166(5):1541-54
pubmed: 15855653
Mol Cell Proteomics. 2005 Dec;4(12):2010-21
pubmed: 16249172
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18226-31
pubmed: 24145418
Nat Chem Biol. 2018 May;14(5):431-441
pubmed: 29581585
Mod Pathol. 2005 Sep;18(9):1249-57
pubmed: 15803180
Eur J Cancer. 2019 Mar;109:137-153
pubmed: 30721788
J Biol Chem. 2010 Apr 16;285(16):12279-88
pubmed: 20172859
Oncotarget. 2017 Jan 3;8(1):846-862
pubmed: 27903987
Cell. 2010 May 14;141(4):583-94
pubmed: 20478252
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nature. 2017 Aug 17;548(7667):343-346
pubmed: 28792927
Nat Chem Biol. 2015 Aug;11(8):611-7
pubmed: 26075522
Cancer Cell. 2018 May 14;33(5):890-904.e5
pubmed: 29657129
Science. 2018 Oct 26;362(6413):
pubmed: 30361341
Pigment Cell Melanoma Res. 2014 Mar;27(2):309-16
pubmed: 24314235
Methods Enzymol. 2012;504:293-313
pubmed: 22264541
Clin Cancer Res. 2004 Nov 1;10(21):7252-9
pubmed: 15534099
Mol Cancer Ther. 2019 Nov;18(11):1985-1996
pubmed: 31308077
Cell. 2007 Mar 9;128(5):889-900
pubmed: 17320163
Cell. 2018 Aug 9;174(4):843-855.e19
pubmed: 30017245
J Biol Chem. 2014 Jun 20;289(25):17620-33
pubmed: 24802759
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Mol Cell. 2007 Mar 23;25(6):801-12
pubmed: 17363312
Nature. 2017 Jul 27;547(7664):453-457
pubmed: 28678785
Mol Cell Biol. 2007 Oct;27(20):7220-35
pubmed: 17709396
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13679-13684
pubmed: 29229836
Int J Cancer. 2008 Mar 1;122(5):1047-57
pubmed: 17973255
Cell Stem Cell. 2017 Feb 2;20(2):233-246.e7
pubmed: 27989769
Cancer Discov. 2016 Jun;6(6):650-63
pubmed: 27179036
J Biol Chem. 2003 Jun 6;278(23):20507-13
pubmed: 12657635
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Cancer Cell. 2014 Jun 16;25(6):762-77
pubmed: 24937458
PLoS One. 2013 Oct 03;8(10):e76550
pubmed: 24098529
Exp Dermatol. 2015 Feb;24(2):155-7
pubmed: 25453510
EMBO J. 2011 Sep 06;30(21):4450-64
pubmed: 21897363
Nature. 2017 Jun 15;546(7658):431-435
pubmed: 28607484
FASEB J. 2015 Nov;29(11):4670-81
pubmed: 26207029
Neural Regen Res. 2013 Dec 25;8(36):3401-9
pubmed: 25206662
Mol Cell Proteomics. 2012 Mar;11(3):O111.013698
pubmed: 22159718
Cell. 2021 Jan 7;184(1):226-242.e21
pubmed: 33417860
Genome Biol. 2006;7(10):R100
pubmed: 17076895

Auteurs

Heike Chauvistré (H)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.

Batool Shannan (B)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.

Sheena M Daignault-Mill (SM)

The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, QLD, Australia.

Robert J Ju (RJ)

The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, QLD, Australia.

Daniel Picard (D)

German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.
Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.
Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

Stefanie Egetemaier (S)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.

Renáta Váraljai (R)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.

Christine S Gibhardt (CS)

Molecular Physiology, Institute of Cardiovascular Physiology, University Medical Center, Georg-August-University, Göttingen, Germany.

Antonio Sechi (A)

Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University Medical School, Aachen, Germany.

Farnusch Kaschani (F)

Department of Chemical Biology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.
Center for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Oliver Keminer (O)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Schnackenburgallee 114, 22525, Hamburg, Germany.
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Schnackenburgallee 114, 22525, Hamburg, Germany.

Samantha J Stehbens (SJ)

The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, QLD, Australia.

Qin Liu (Q)

The Wistar Institute, Philadelphia, PA, USA.

Xiangfan Yin (X)

The Wistar Institute, Philadelphia, PA, USA.

Kirujan Jeyakumar (K)

Faculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Strasse 4a, 44227, Dortmund, Germany.

Felix C E Vogel (FCE)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.
Division of Tumor Metabolism and Microenvironment, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Clemens Krepler (C)

The Wistar Institute, Philadelphia, PA, USA.

Vito W Rebecca (VW)

The Wistar Institute, Philadelphia, PA, USA.

Linda Kubat (L)

German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.
Translational Skin Cancer Research (TSCR), German Cancer Consortium (DKTK), University Hospital of Essen, Universitätsstrasse 1, 45141, Essen, Germany.

Smiths S Lueong (SS)

German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.
Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Hospital Essen, 45122, Essen, Germany.

Jan Forster (J)

German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.
Department of Human Genetics, University Hospital Essen, University Duisburg-Essen, Hufelandstrasse 55, 45122, Essen, Germany.

Susanne Horn (S)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.

Marc Remke (M)

German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.
Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.
Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

Michael Ehrmann (M)

Center for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.
Department of Microbiology, University of Duisburg-Essen, Universitätsstraße 2, 45117, Essen, Germany.

Annette Paschen (A)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.

Jürgen C Becker (JC)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.
Translational Skin Cancer Research (TSCR), German Cancer Consortium (DKTK), University Hospital of Essen, Universitätsstrasse 1, 45141, Essen, Germany.

Iris Helfrich (I)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.

Daniel Rauh (D)

Faculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Strasse 4a, 44227, Dortmund, Germany.

Markus Kaiser (M)

Department of Chemical Biology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.
Center for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Sheraz Gul (S)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Schnackenburgallee 114, 22525, Hamburg, Germany.
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Schnackenburgallee 114, 22525, Hamburg, Germany.

Meenhard Herlyn (M)

The Wistar Institute, Philadelphia, PA, USA.

Ivan Bogeski (I)

Molecular Physiology, Institute of Cardiovascular Physiology, University Medical Center, Georg-August-University, Göttingen, Germany.

José Neptuno Rodríguez-López (JN)

GENZ-Group of Research on Enzymology, Department of Biochemistry and Molecular Biology-A, Regional Campus of International Excellence 'Campus Mare Nostrum', University of Murcia, Murcia, Spain.

Nikolas K Haass (NK)

The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, QLD, Australia.

Dirk Schadendorf (D)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany.
Center for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Alexander Roesch (A)

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany. alexander.roesch@uk-essen.de.
German Consortium for Translational Cancer Research (DKTK), Partner Site Essen/Düsseldorf, Essen/Düsseldorf, Germany. alexander.roesch@uk-essen.de.
Center for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany. alexander.roesch@uk-essen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH